NIH guidelines for research involving recombinant DNA molecules.
نویسنده
چکیده
This notice sets forth actions taken by the Director, National Institute of Allergy and infectious Diseases (NIAID), by authority of the Director. NIH, under the June 1983 NIH Guidelines for Research Involving Recombinant DNA Molecules (48 FR 24556).
منابع مشابه
The National Institutes of Health system for enhancing the science, safety, and ethics of recombinant DNA research.
Oversight of recombinant DNA research by the National Institutes of Health (NIH) is predicated on ethical and scientific responsibilities that are akin, in many ways, to those that pertain to the oversight of animal research. The NIH system of oversight, which originated more than 25 years ago, is managed by the NIH Office of Biotechnology Activities (OBA), which uses various tools to fulfill i...
متن کاملDepartment of Health and Human Services, National Institutes of Health. Recombinant DNA research: actions under the guidelines.
This notice sets forth proposed actions to be taken under the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant DNA Molecules. Interested parties are invited to submit comments concerning these proposals. These proposals will be considered by the Recombinant DNA Advisory Committee (RAC) at its meeting on October 16, 1990. After consideration of these proposals an...
متن کاملGuidelines for research involving recombinant DNA molecules.
The newest version of the “Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) is dated September 2009. In time, these Guidelines will be updated and the newest published version will dictate our College’s Guidelines for r-DNA research applications for approval where an IBC decision or input is mandated. The PI leading the research is responsible for reading the most re...
متن کاملA History of the Recombinant Dna Guidelines in the United States
On December 16, 1978, a telegram purporting to be from the Vatican was handdelivered to the office of Joseph A. Califano, Jr., Secretary of Health, Education, and Welfare. "Habemus regimen recombinatum," it proclaimed, in celebration of the end of a long struggle to revise the NIH Guidelines for Research Involving Recombinant DNA Molecules. It was not the first telegram the Secretary had receiv...
متن کاملAssessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
Given the nature of clinical research, it is not uncommon for gravely ill participants to succumb to their underlying disease in the course of a trial. However, in September, 1999, the gene transfer research community was alerted to the report of the death of a young man enrolled in a gene transfer trial at the University of Pennsylvania.1 In this case, the research participant was not in extre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Recombinant DNA technical bulletin
دوره 7 2 شماره
صفحات -
تاریخ انتشار 1983